scispace - formally typeset
Search or ask a question

Showing papers by "William Borkowsky published in 2005"

Journal Article•DOI•
Ritonavir-Based Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Infants Younger Than 24 Months of Age

[...]

Ellen G. Chadwick1, John H. Rodman, Paula Britto2, Christine A. Powell2, Paul Palumbo3, Katherine Luzuriaga4, Michael Hughes2, Elaine J. Abrams5, Patricia M. Flynn, William Borkowsky6, Ram Yogev •
Northwestern University1, Harvard University2, Rutgers University3, University of Massachusetts Medical School4, Columbia University5, New York University6
01 Sep 2005-Pediatric Infectious Disease Journal
TL;DR: A combination regimen of ritonavir, zidovudine and lamivudine was generally safe and produced sustained viral suppression in more than one-third of infants who initiated therapy before 2 years of age.
Abstract: Background:Few data are available regarding clinical outcomes or dosing requirements for the protease inhibitor ritonavir in human immunodeficiency virus (HIV)-infected children younger than under 24 months of age.Methods:This prospective, multicenter phase I/II open label treatment trial used riton

35 citations